Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 2
1994 3
1995 2
1996 4
1997 6
1998 2
1999 5
2000 1
2001 7
2002 9
2003 10
2004 9
2005 9
2006 6
2007 6
2008 11
2009 6
2010 12
2011 8
2012 6
2013 6
2014 10
2015 10
2016 20
2017 15
2018 15
2019 14
2020 28
2021 28
2022 10
2023 11
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of Insulin Secretion and Insulin Resistance in Human.
Park SY, Gautier JF, Chon S. Park SY, et al. Among authors: gautier jf. Diabetes Metab J. 2021 Sep;45(5):641-654. doi: 10.4093/dmj.2021.0220. Epub 2021 Sep 30. Diabetes Metab J. 2021. PMID: 34610719 Free PMC article. Review.
High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold.
Castera L, Laouenan C, Vallet-Pichard A, Vidal-Trécan T, Manchon P, Paradis V, Roulot D, Gault N, Boitard C, Terris B, Bihan H, Julla JB, Radu A, Poynard T, Brzustowsky A, Larger E, Czernichow S, Pol S, Bedossa P, Valla D, Gautier JF; QUID-NASH investigators. Castera L, et al. Among authors: gautier jf. Diabetes Care. 2023 Jul 1;46(7):1354-1362. doi: 10.2337/dc22-2048. Diabetes Care. 2023. PMID: 37043830
Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes.
Julla JB, Girard D, Diedisheim M, Saulnier PJ, Tran Vuong B, Blériot C, Carcarino E, De Keizer J, Orliaguet L, Nemazanyy I, Potier C, Khider K, Tonui DC, Ejlalmanesh T, Ballaire R, Mambu Mambueni H, Germain S, Gaborit B, Vidal-Trécan T, Riveline JP, Garchon HJ, Fenaille F, Lemoine S, Carlier A, Castelli F, Potier L, Masson D, Roussel R, Vandiedonck C, Hadjadj S, Alzaid F, Gautier JF, Venteclef N. Julla JB, et al. Among authors: gautier jf. Circ Res. 2024 Jan 19;134(2):189-202. doi: 10.1161/CIRCRESAHA.123.322757. Epub 2023 Dec 28. Circ Res. 2024. PMID: 38152893 Free article.
Gene expression signature predicts rate of type 1 diabetes progression.
Suomi T, Starskaia I, Kalim UU, Rasool O, Jaakkola MK, Grönroos T, Välikangas T, Brorsson C, Mazzoni G, Bruggraber S, Overbergh L, Dunger D, Peakman M, Chmura P, Brunak S, Schulte AM, Mathieu C, Knip M, Lahesmaa R, Elo LL; INNODIA Consortium. Suomi T, et al. EBioMedicine. 2023 Jun;92:104625. doi: 10.1016/j.ebiom.2023.104625. Epub 2023 May 22. EBioMedicine. 2023. PMID: 37224769 Free PMC article.
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes.
Castera L, Garteiser P, Laouenan C, Vidal-Trécan T, Vallet-Pichard A, Manchon P, Paradis V, Czernichow S, Roulot D, Larger E, Pol S, Bedossa P, Correas JM, Valla D, Gautier JF, Van Beers BE; QUID NASH investigators. Castera L, et al. Among authors: gautier jf. J Hepatol. 2024 Aug;81(2):195-206. doi: 10.1016/j.jhep.2024.03.023. Epub 2024 Mar 27. J Hepatol. 2024. PMID: 38548067
Heterogeneity of glycaemic phenotypes in type 1 diabetes.
Fagherazzi G, Aguayo GA, Zhang L, Hanaire H, Picard S, Sablone L, Vergès B, Hamamouche N, Detournay B, Joubert M, Delemer B, Guilhem I, Vambergue A, Gourdy P, Hadjadj S, Velayoudom FL, Guerci B, Larger E, Jeandidier N, Gautier JF, Renard E, Potier L, Benhamou PY, Sola A, Bordier L, Bismuth E, Prévost G, Kessler L, Cosson E, Riveline JP; SFDT1 study team. Fagherazzi G, et al. Among authors: gautier jf. Diabetologia. 2024 Aug;67(8):1567-1581. doi: 10.1007/s00125-024-06179-4. Epub 2024 May 23. Diabetologia. 2024. PMID: 38780786 Free PMC article.
ACBP/DBI neutralization for the experimental treatment of fatty liver disease.
Motiño O, Lambertucci F, Joseph A, Durand S, Anagnostopoulos G, Li S, Carbonnier V, Nogueira-Recalde U, Montégut L, Chen H, Aprahamian F, Nirmalathasan N, Maiuri MC, Pietrocola F, Valla D, Laouénan C, Gautier JF, Castera L; QUID NASH Investigators; Martins I, Kroemer G. Motiño O, et al. Among authors: gautier jf. Cell Death Differ. 2024 Nov 16. doi: 10.1038/s41418-024-01410-6. Online ahead of print. Cell Death Differ. 2024. PMID: 39550516
Incretin-based therapy and pancreatic beta cells.
Chon S, Riveline JP, Blondeau B, Gautier JF. Chon S, et al. Among authors: gautier jf. Diabetes Metab. 2014 Dec;40(6):411-22. doi: 10.1016/j.diabet.2014.05.003. Diabetes Metab. 2014. PMID: 25443548 Review.
Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy.
Ancel P, Martin JC, Doukbi E, Houssays M, Gascon P, Righini M, Matonti F, Svilar L, Valmori M, Tardivel C, Venteclef N, Julla JB, Gautier JF, Resseguier N, Dutour A, Gaborit B. Ancel P, et al. Among authors: gautier jf. Int J Mol Sci. 2023 Jul 27;24(15):12053. doi: 10.3390/ijms241512053. Int J Mol Sci. 2023. PMID: 37569425 Free PMC article.
255 results